Transthyretin Cardiac Amyloidosis Fellowship Competitive Grant Program

Funding Agency:
Pfizer Inc.

Pfizer Global Medical Grants (GMG) supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies. Pfizer’s GMG competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest, sets timelines for review and approval, and uses an external review panel (ERP). Institutions are invited to submit an application as outlined in the specific RFP.

It is our intent to support institutions with fellowship programs for Cardiologists that have a strong focus on clinical practice, research, and education to further the understanding of transthyretin cardiac amyloidosis.

Grants will be available for both established and emerging Amyloid Centers of Excellence.

Full Proposal Deadline: June 15, 2021

Agency Website

Eligibility Requirements

Geographic Scope: United States with interest in supporting both established and emerging Amyloid Centers of Excellence

• Accredited, US-based academic institution. • Do not include the name of the potential fellow(s) in application materials. This grant will be awarded to an institution, not an individual. • Institutions with fellowship programs that include independent research and a strong mentoring program. Clinical training may be included in the program but is not required. • No aspect of the fellowship program can benefit Pfizer’s business or a Pfizer asset. • Examples of independent research include: observational studies and outcomes research studies where the primary focus is the scientific understanding of disease; use of screening tools and their impact on improvement of patient health. o Examples of research that would not be eligible include research involving the study and/or evaluation of any pharmaceutical product and basic science and/or fundamental research (in animal model, in-vitro, etc.). • Examples of clinical training include: educational time with an interdisciplinary team in review of case examples and relevant didactic training as well as use of tools for improvement in patient health for specific therapeutic areas or conditions. • Fellow time spent in the clinical setting that is supported through grant funds must not be billed as patient care.

Amount Description

• Grant funding is available to support one fellow for up to a year at $80,000. The budget can include salary and support of the fellow benefits. There is a total budget of $240,000 for this program.

Funding Type





Curriculum Development
Medical - Clinical Science

External Deadline

June 15, 2021